Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.

Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K, Chen L.

Nat Immunol. 2001 Mar;2(3):269-74.

PMID:
11224528
2.

Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains.

Steinberger P, Majdic O, Derdak SV, Pfistershammer K, Kirchberger S, Klauser C, Zlabinger G, Pickl WF, Stöckl J, Knapp W.

J Immunol. 2004 Feb 15;172(4):2352-9.

3.
4.

Soluble mouse B7-H3 down-regulates dendritic cell stimulatory capacity to allogenic T cell proliferation and production of IL-2 and IFN-gamma.

Xu J, Huang B, Xiong P, Feng W, Xu Y, Fang M, Zheng F, Gong F.

Cell Mol Immunol. 2006 Jun;3(3):235-40.

5.

B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function.

Tamura H, Dong H, Zhu G, Sica GL, Flies DB, Tamada K, Chen L.

Blood. 2001 Mar 15;97(6):1809-16.

6.

Characterization of mouse and human B7-H3 genes.

Sun M, Richards S, Prasad DV, Mai XM, Rudensky A, Dong C.

J Immunol. 2002 Jun 15;168(12):6294-7.

7.

Expression of programmed death 1 ligands by murine T cells and APC.

Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, Azuma M, Yagita H.

J Immunol. 2002 Nov 15;169(10):5538-45.

8.

Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.

Yamazaki T, Akiba H, Koyanagi A, Azuma M, Yagita H, Okumura K.

J Immunol. 2005 Aug 1;175(3):1586-92.

9.

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.

Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Pai SI, Shalabi A, Shin T, Pardoll DM, Tsuchiya H.

J Exp Med. 2001 Apr 2;193(7):839-46.

10.

Murine B7-H3 is a negative regulator of T cells.

Prasad DV, Nguyen T, Li Z, Yang Y, Duong J, Wang Y, Dong C.

J Immunol. 2004 Aug 15;173(4):2500-6.

11.

Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.

Kobori H, Hashiguchi M, Piao J, Kato M, Ritprajak P, Azuma M.

Immunology. 2010 Jul;130(3):363-73. doi: 10.1111/j.1365-2567.2009.03236.x. Epub 2010 Feb 5.

12.
13.

The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.

Wiendl H, Neuhaus O, Mehling M, Wintterle S, Schreiner B, Mitsdoerffer M, Wienhold W, Weissert R, Wessels J, Hartung HP, Weller M, Tolosa E, Melms A.

J Neuroimmunol. 2003 Jul;140(1-2):177-87.

PMID:
12864987
15.

Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses.

Hashiguchi M, Kobori H, Ritprajak P, Kamimura Y, Kozono H, Azuma M.

Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10495-500. doi: 10.1073/pnas.0802423105. Epub 2008 Jul 23. Erratum in: Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14744.

16.

Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells.

Zhu M, Terasawa H, Gulley J, Panicali D, Arlen P, Schlom J, Tsang KY.

Cancer Res. 2001 May 1;61(9):3725-34.

17.
18.

Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.

Trabattoni D, Saresella M, Pacei M, Marventano I, Mendozzi L, Rovaris M, Caputo D, Borelli M, Clerici M.

J Immunol. 2009 Oct 15;183(8):4984-93. doi: 10.4049/jimmunol.0901038. Epub 2009 Sep 30.

19.

Immunomodulatory drug costimulates T cells via the B7-CD28 pathway.

LeBlanc R, Hideshima T, Catley LP, Shringarpure R, Burger R, Mitsiades N, Mitsiades C, Cheema P, Chauhan D, Richardson PG, Anderson KC, Munshi NC.

Blood. 2004 Mar 1;103(5):1787-90. Epub 2003 Sep 25.

20.

LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response.

Tamada K, Shimozaki K, Chapoval AI, Zhai Y, Su J, Chen SF, Hsieh SL, Nagata S, Ni J, Chen L.

J Immunol. 2000 Apr 15;164(8):4105-10.

Supplemental Content

Support Center